CIMZIA(R) (certolizumab Pegol) Reduces Intestinal Lesions And Induces Endoscopic Improvement In Crohn's Patients UCB presented data from a large, prospective study investigating endoscopic improvement in Crohn's disease (CD) with a biologic compound.
Source: www.medicalnewstoday.comSudden Infant Death Syndrome (SIDS) Risk Decreased With Use Of Fan Using a fan while an infant is sleeping in a room with inadequate ventilation can decrease the risk of that infant dying of sudden infant death syndrome (SIDS), according to a report released on October 6, 2008 in Archives of Pediatrics & Adolescent
Medicine, one of the JAMA/Archives journals. Sudden infant death syndrome, sometimes called cot death or crib death, describes the unexpected, unexplained death of an apparently
health infant.
Source: www.medicalnewstoday.comIronwood And Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain Ironwood Pharmaceuticals (formerly Microbia) announced presentation of data from a pair of preclinical studies delineating the role that cyclic guanosine monophosphate (cGMP) plays in alleviating intestinal pain. These studies demonstrate that cGMP inhibits intestinal pain in a preclinical model of intestinal hyperalgesia and desensitizes colonic afferent nerves in a similar model of experimental colitis.
Source: www.medicalnewstoday.comNew Survey Shows Pregnant Women Unaware, Misinformed About Flu Shot Benefits During Pregnancy Despite national
health experts' long-standing recommendation that women receive a flu shot while pregnant, three-quarters of women responding to a new national survey are unaware or unsure of these recommendations, and only 20 percent of those who are currently pregnant plan to get a flu shot this influenza season.
Source: www.medicalnewstoday.comDendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial Dendreon Corporation (Nasdaq: DNDN) announced that it has completed the planned interim analysis of the Phase 3, randomized, double-blind, placebo-controlled IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment, also known as D9902B) clinical trial designed to
Source: www.medicalnewstoday.com
# posted by Network @ 4:00 AM
